Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.54 |
| ▸ | NEK2 | P51955 | 1/20 | 0.54 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.54 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.54 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL27737084 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL29364795 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL29555314 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrochloric Acid SCHEMBL28099546 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrogen Sulfide SCHEMBL3359211 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrochloric Acid SCHEMBL2866027 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL2174491 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrochloric Acid SCHEMBL31515359 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Nitrogen SCHEMBL27346241 | 0.93 | SIGMAR1 (0.59) | SIGMAR1MCL1KDM4EGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4426535-A | Method of synthesizing brevicomin and using same in beetle control | UNIVERSITY OF PITTSBURGH (US) | 1984-01-17 | — | — | US | claimed |
| JP-11255779-A | — | — | None | — | — | JP | disclosed |
| EP-3275855-B1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHINETSU CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10138189-B2 | Methods for producing 2,6-dimethyl-1,5-heptadien-3-ol and 2,6-dimethyl-1,5-heptadien-3-yl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-11-27 | — | — | US | disclosed |
| CN-107663145-A | Method for producing the alcohol of 2,6 dimethyl, 1,5 heptadiene 3 and its acetic acid esters | 信越化学工业株式会社 | 2018-02-06 | — | — | CN | disclosed |
| US-20180029964-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3275855-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-01-31 | — | — | EP | disclosed |
| EP-1700860-B1 | POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, INTERMEDIATE THEREFOR, PROCESS FOR PRODUCING POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS, AND PROCESS FOR PRODUCING INTERMEDIATE FOR POLYCYCLIC FUSED RING TYPE PI-CONJUGATED ORGANIC MATERIALS | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-7973190-B2 | Polycyclic fused ring type π-conjugated organic material, intermediate therefor, process for producing polycyclic fused ring type π-conjugated organic material, and process for producing intermediate of polycyclic fused ring type π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7705174-B2 | Condensed polycyclic π-conjugated organic material, intermediate product therefor, and method of manufacturing condensed polycyclic π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-27 | — | — | US | disclosed |
| EP-0268400-B1 | STEROIDAL 17ALPHA-SILYL ETHERS AND PROCESS TO CORTICOIDS AND PROGESTERONES | THE UPJOHN COMPANY (US) | 1992-04-29 | — | — | EP | disclosed |
| US-4977255-A | Steroidal 17α-silyl ethers and process to corticoids and progesterones | THE UPJOHN COMPANY (US) | 1990-12-11 | — | — | US | disclosed |
| US-4921638-A | 17β-cyano-9α,17α-dihydroxyandrost-4-en-3-one | THE UPJOHN COMPANY (US) | 1990-05-01 | — | — | US | disclosed |
| EP-0334875-A1 | STEROIDAL 17$g(a)-SILYL ETHERS AND PROCESS TO CORTICOIDS AND PROGGESTERONES | THE UPJOHN COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
| EP-0169300-B1 | PROCESS FOR PREPARATION OF ALPHA-ALKYL AMINO ACIDS | MERCK & CO. INC. (US) | 1988-05-25 | — | — | EP | disclosed |
| EP-0268400-A1 | Steroidal 17alpha-silyl ethers and process to corticoids and progesterones | THE UPJOHN COMPANY (US) | 1988-05-25 | — | — | EP | disclosed |
| WO-1988003534-A1 | STEROIDAL 17alpha-SILYL ETHERS AND PROCESS TO CORTICOIDS AND PROGGESTERONES | THE UPJOHN COMPANY (US) | 1988-05-19 | — | — | WO | disclosed |
| US-4695584-A | Method of synthesizing brevicomin and using same in beetle control | UNIVERSITY OF PITTSBURGH (US) | 1987-09-22 | — | — | US | disclosed |
| US-4508921-A | Process for preparation of alpha-alkyl amino acids | MERCK & CO., INC. (US) | 1985-04-02 | — | — | US | disclosed |
| US-4426535-A | Method of synthesizing brevicomin and using same in beetle control | UNIVERSITY OF PITTSBURGH (US) | 1984-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180029964-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | MSMO1, CYP8B1, ACMSD | SIGMAR1 848/4885MCL1 3438/4885KDM4E 153/4885 |
| US-10138189-B2 | Methods for producing 2,6-dimethyl-1,5-heptadien-3-ol and 2,6-dimethyl-1,5-heptadien-3-yl acetate | MSMO1, CYP8B1, ACMSD | SIGMAR1 848/4885MCL1 3438/4885KDM4E 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.